502649-34-5 Usage
Uses
Used in Organic Synthesis:
4-Iso-propoxyphenylboronic acid pinacol ester is used as a reagent in organic synthesis for its ability to form carbon-carbon bonds through Suzuki-Miyaura cross-coupling reactions. This capability is crucial for the construction of complex organic molecules and the synthesis of various pharmaceutical compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-Iso-propoxyphenylboronic acid pinacol ester is utilized as a key intermediate in the development of new drugs. Its unique structure and reactivity contribute to the discovery and optimization of potential therapeutic agents.
Used in Drug Discovery and Development:
4-Iso-propoxyphenylboronic acid pinacol ester is employed as a precursor in drug discovery and development processes. Its involvement in the synthesis of bioactive molecules allows for the exploration of new chemical entities with potential therapeutic applications.
Used in Pharmaceutical Compound Preparation:
This organoboron compound is used as a building block in the preparation of pharmaceutical compounds, where its reactivity in cross-coupling reactions facilitates the creation of diverse and complex molecular structures with potential medicinal properties.
Check Digit Verification of cas no
The CAS Registry Mumber 502649-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,2,6,4 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 502649-34:
(8*5)+(7*0)+(6*2)+(5*6)+(4*4)+(3*9)+(2*3)+(1*4)=135
135 % 10 = 5
So 502649-34-5 is a valid CAS Registry Number.
502649-34-5Relevant articles and documents
Remote steric control for undirected meta-selective C-H activation of arenes
Asako, Sobi,Ilies, Laurean,Jin, Yushu,Ramadoss, Boobalan
, p. 658 - 663 (2022/02/21)
Regioselective functionalization of arenes remains a challenging problem in organic synthesis. Steric interactions are often used to block sites adjacent to a given substituent, but they do not distinguish the remaining remote sites. We report a strategy
PIPERAZINE AND HOMOPIPERAZINE COMPOUNDS
-
, (2008/06/13)
Compounds are provided having a piperazine or homopiperazine ring which are useful in the treatment of thrombosis.